Novabiotics - a leading clinical-stage biotechnology company
Novabiotics about us Novabiotics clinical studies Novabiotics pipeline Novabiotics our news Novabiotics contact

CEO Dr Deborah O’Neil and the NovaBiotics team will be attending the BIO CEO & Investor Conference, hosted by the Biotechnology Innovation Organization on the 16th-18th February 2021.  Meet with us through the event portal BIO CEO & Investor Event to learn more about our financing plans and strategy for our exciting pipeline of first-in-class antimicrobial and respiratory product candidates including Nylexa for Covid-19.